TrialAddiction biology2022

Results from a randomized, double-blind, placebo-controlled, crossover, multimodal-MRI pilot study of gabapentin for co-occurring bipolar and cannabis use disorders.

James J Prisciandaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.